Certolizumab Pegol

Common brands: Cimzia, Methotrexate, Rasuvo, Otrexup, Trexall

Top reporter: Ucb, Inc.

Tumor Necrosis Factor Blocker [EPC]Folate Analog Metabolic Inhibitor [EPC]Corticosteroid [EPC]Antirheumatic Agent [EPC]Interleukin-6 Receptor Antagonist [EPC]
114,573
Total Reports
56,658
Serious Reports
6,313
Death Reports
30
Reported Reactions
Death Report Ratio: High (5.51%)

Patient Demographics

Male
20,476
Female
83,648

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Certolizumab Pegol.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 26,772
9.3%
2 RHEUMATOID ARTHRITIS 19,436
6.8%
3 PAIN 15,697
5.5%
4 FATIGUE 13,479
4.7%
5 OFF LABEL USE 11,345
3.9%
6 RASH 10,935
3.8%
7 ARTHRALGIA 10,779
3.8%
8 ALOPECIA 10,079
3.5%
9 JOINT SWELLING 9,728
3.4%
10 ABDOMINAL DISCOMFORT 9,492
3.3%
11 MATERNAL EXPOSURE DURING PREGNANCY 9,443
3.3%
12 SYSTEMIC LUPUS ERYTHEMATOSUS 9,041
3.1%
13 PEMPHIGUS 8,638
3.0%
14 DRUG INTOLERANCE 8,629
3.0%
15 SWELLING 8,628
3.0%
16 HYPERSENSITIVITY 8,191
2.8%
17 CONTRAINDICATED PRODUCT ADMINISTERED 8,167
2.8%
18 GLOSSODYNIA 8,021
2.8%
19 ARTHROPATHY 7,998
2.8%
20 SYNOVITIS 7,287
2.5%
21 HAND DEFORMITY 7,153
2.5%
22 HEADACHE 7,006
2.4%
23 PSORIATIC ARTHROPATHY 6,786
2.4%
24 CONDITION AGGRAVATED 6,649
2.3%
25 INFECTION 6,599
2.3%
26 WOUND 6,599
2.3%
27 NAUSEA 6,440
2.2%
28 DIARRHOEA 6,153
2.1%
29 INFUSION RELATED REACTION 6,140
2.1%
30 HEPATIC ENZYME INCREASED 6,129
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.